Dynocardia, Inc.

Name: Dynocardia, Inc.
Address: 1 Broadway, Cambridge, Massachusetts, United States, 02142, Cambridge
Telephone: '+1 617-639-5569

Cambridgemedical devices

About

Dynocardia, Inc. is a medical technology company based in Newton Center, Massachusetts, founded in 2018. The company has received significant support from Tufts University and the Massachusetts Institute of Technology (MIT), along with approximately $5.1 million in funding from the National Heart, Lung, and Blood Institute (NHLBI) and additional backing from the National Science Foundation (NSF). Dynocardia is currently in the Series A-II funding stage, having raised a total of $12.42 million. The company's flagship product, ViTrack™, is a cuff-less, wrist-wearable device designed for continuous, non-invasive blood pressure monitoring. ViTrack utilizes a proprietary optical force sensor and computer-vision technology to provide accurate measurements, even during patient movement. It also monitors heart rate, respiratory rate, and other cardio-hemodynamic parameters. ViTrack is being tested in clinical trials and is aimed at various care settings, including hospitals, intensive care units, and remote patient monitoring, with plans to expand into the consumer wellness market.